Netupitant + Palonosetron Capsules Suppliers & Bulk Manufacturers

Available Forms: Capsules

Available Strengths: 300 mg netupitant and 0.5 mg palonosetron

Reference Brands: Akynzeo(US & EU)

Category: Antiemetic

Netupitant + Palonosetron Capsules is available in Capsules and strengths such as 300 mg netupitant and 0.5 mg palonosetron. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Netupitant + Palonosetron Capsules is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.

Netupitant + Palonosetron Capsules can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.

Product Description: Netupitant + Palonosetron capsules, marketed as Akynzeo, are approved in the US by the FDA and in the EU via EMA for preventing chemotherapy-induced nausea and vomiting. Regulatory approval requires a detailed dossier including clinical efficacy, safety data, manufacturing standards, and pharmacovigilance plans. The FDA reviews comprehensive clinical trial and quality data for timely approval, while the EMA ensures compliance with regional safety and manufacturing regulations. For guidance on dossier preparation, regulatory pathways, and market access, visit PharmaTradz. Proper adherence supports swift approval, safe use, and global availability, helping cancer patients better manage nausea and improve treatment adherence worldwide.